Cocrystal Pharma Inc (COCP): Bathi saben saham sajrone rolas wulan pungkasan

Effective management at Cocrystal Pharma, Inc. (COCP) ensures strict control over R&D expenditures and testing transparency. The rolling annual earnings per share demonstrate resilience, where -0.77 determines this parameter level. The company complies with environmental waste disposal regulations, establishing a foundation for the monetization of antiviral patents through strategic partnerships with industry behemoths.

Cocrystal Pharma, Inc. (COCP) - Bathi resik saben saham (EPS TTM) saka 04.07.2022 nganti 14.11.2026

COCP (Cocrystal Pharma Corp): rincian analitis lan laporan miturut indikator

- rega saham lan target rega konsensus:

Rega saham Cocrystal Pharma Inc|COCP - Target median analis

- data kapitalisasi bursa:

Nilai pasar Cocrystal Pharma Corp|COCP - Nilai Dipunlarasaken Utang lan Kas

- data nilai buku modal saham:

Nilai Akuntansi saben Saham Cocrystal Pharma|COCP - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku cocrystalpharma.com|COCP - Gunggung Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Total Utang marang Modal Cocrystal Pharma, Inc.|COCP - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Cocrystal Pharma Inc|COCP - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Cocrystal Pharma Corp|COCP - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Cocrystal Pharma|Indikator likuiditas cepet cocrystalpharma.com

- indikator bathi lan kelipatan valuasi:

COCP - Penghasilan resik perusahaan|Bathi sing dikarepake Cocrystal Pharma, Inc.|COCP - Periode bali modal bisnis|Prakiraan rega marang bathi Cocrystal Pharma|COCP - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Cocrystal Pharma Inc|COCP - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Cocrystal Pharma|COCP - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan cocrystalpharma.com|COCP - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cocrystal Pharma, Inc.

- data dodolan lan asil:

COCP - Pendapatan tahunan perusahaan|Prakiraan volume dodolan Cocrystal Pharma|COCP - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S Cocrystal Pharma Inc

Analisis dhasar perusahaan:Cocrystal Pharma Inc (COCP)

Asset managers require an objective assessment of the actual yield for each of the issuer's shares. This indicator calculates the total annual net income divided by the total number of shares. Analyzing the 12-month per-share net income chart allows for the identification of hidden risks regarding stagnant operational inflows. For Cocrystal Pharma, Inc. (COCP), this metric reflects the investment stage of its antiviral developments. Growth in this metric is expected following the commercialization of drugs against influenza and COVID-19.

Analisis pesaing